Reduction in Thyroid Perfusion After Bevacizumab Treatment

被引:6
作者
van der Veldt, Astrid A. M. [1 ,2 ]
Lammertsma, Adriaan A. [2 ]
Smit, Egbert F. [3 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, NL-1007 MB Amsterdam, Netherlands
关键词
VEGF; SUNITINIB; CANCER;
D O I
10.1089/thy.2013.0147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1329 / 1330
页数:2
相关论文
共 10 条
  • [1] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [2] Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
    Ferrara, N
    Hillan, KJ
    Gerber, HP
    Novotny, W
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) : 391 - 400
  • [3] The biology of VEGF and its receptors
    Ferrara, N
    Gerber, HP
    LeCouter, J
    [J]. NATURE MEDICINE, 2003, 9 (06) : 669 - 676
  • [4] VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
    Kamba, T
    Tam, BYY
    Hashizume, H
    Haskell, A
    Sennino, B
    Mancuso, MR
    Norberg, SM
    O'Brien, SM
    Davis, RB
    Gowen, LC
    Anderson, KD
    Thurston, G
    Joho, S
    Springer, ML
    Kuo, CJ
    McDonald, DM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (02): : H560 - H576
  • [5] Tyrosine Kinase Inhibitor-Induced Thyroid Disorders: A Review and Hypothesis
    Makita, Noriko
    Iiri, Taroh
    [J]. THYROID, 2013, 23 (02) : 151 - 159
  • [6] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Rixe, Olivier
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Kim, Sindy T.
    Chen, Isan
    Bycott, Paul W.
    Baum, Charles M.
    Figlin, Robert A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 115 - 124
  • [7] Hester van Cruijs']jsen, Astrid van der Veldt, Klaas Hoekman
    van Cruijsen, Hester
    van der Veldt, Astrid
    Hoekman, Klaas
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 2248 - 2268
  • [8] Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
    Van der Veldt, Astrid A. M.
    Lubberink, Mark
    Bahce, Idris
    Walraven, Maudy
    de Boer, Michiel P.
    Greuter, Henri N. J. M.
    Hendrikse, N. Harry
    Eriksson, Jonas
    Windhorst, Albert D.
    Postmus, Pieter E.
    Verheul, Henk M.
    Serne, Erik H.
    Lammertsma, Adriaan A.
    Smit, Egbert F.
    [J]. CANCER CELL, 2012, 21 (01) : 82 - 91
  • [9] Quantitative Parametric Perfusion Images Using 15O-Labeled Water and a Clinical PET/CT Scanner: Test-Retest Variability in Lung Cancer
    van der Veldt, Astrid A. M.
    Hendrikse, N. Harry
    Harms, Hendrik J.
    Comans, Emile F. I.
    Postmus, Pieter E.
    Smit, Egbert F.
    Lammertsma, Adriaan A.
    Lubberink, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (11) : 1684 - 1690
  • [10] Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib
    van der Veldt, Astrid A. M.
    de Boer, Michiel P.
    Boven, Epie
    Eringa, Etto C.
    van den Eertwegh, Alfons J. M.
    van Hinsbergh, Victor W.
    Smulders, Yvo M.
    Serne, Erik H.
    [J]. ANTI-CANCER DRUGS, 2010, 21 (04) : 439 - 446